Brief: Paratek Pharmaceuticals Announces First Quarter 2022 Revenue Of $24.9 Million
04/05/2022 23:12
May 4 (Reuters) - Paratek Pharmaceuticals Inc PRTK.O :
* PARATEK PHARMACEUTICALS ANNOUNCES FIRST QUARTER 2022
REVENUE OF
$24.9 MILLION
* Q1 REVENUE ROSE 51 PERCENT TO $24.9 MILLION
* CASH RUNWAY THROUGH END OF 2023 WITH A PATHWAY TO CASH
FLOW
BREAK-EVEN
Source text for Eikon: ID:nGNX4dcL8s
Further company coverage: PRTK.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Paratek Pharmaceuticals
See all newsNovo Holdings closes $462 mln acquisition of Paratek Pharmaceuticals
Brief: Glass Lewis Recommends Paratek Pharmaceuticals Stockholders Vote For Acquisition By Gurnet Point Capital And Novo Holdings
Brief: Paratek Pharmaceuticals Responds to Demand Letters From 11 Stockholders Alleging 'Misleading', Incomplete Statements In Proxy Statement Filed On June 30
Brief: Independent Proxy Advisory Firm ISS Recommends Paratek Pharmaceuticals Stockholders Vote For Acquisition By Gurnet Point Capital And Novo Holdings
Brief: Paratek Pharmaceuticals Announces Second Quarter 2023 Revenue Of $40.0 Million